ÂÜÀòÂÒÂ×

Amy Kimzey, PhD DABT, is a highly experienced toxicologist currently employed at ToxStrategies since 2016, where responsibilities include preparing toxicology monographs and conducting non-clinical regulatory submissions. Previously, Amy worked as an independent consultant specializing in discovery and exploratory toxicology from 2013 to 2016, and as a project toxicologist at AstraZeneca from 2005 to 2012, focusing on preclinical safety and toxicology strategies. Earlier positions include roles at Abbott Laboratories, Pintex Pharmaceuticals, and Pacific Northwest National Laboratory, with a foundation in biochemistry and cell biology. Amy holds a PhD in Chemistry from the University of Colorado Boulder and a B.S. in Biochemistry and Biophysics from Oregon State University.